Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188980 · ClinicalTrials.gov registry record
Early Increase in Blood Supply in Patients With Barrett's Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 90
- Enrollment target
NCT01188980: Completed study, sponsored by Mayo Clinic.
NCT01188980 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01188980 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if early Barrett's specialized intestinal metaplasia can be detected by measuring early increased blood supply of the esophageal tissue, with 4 Dimensional Elastic Light-Scattering Fingerprinting, (4D-ELF) technology in real time.
Primary Outcome
To determine if early increase blood supply (EIBS), as measured in Barrett's glandular mucosa segment, can predict the presence of Dysplasia in patients with known diagnosis of Barrett's esophagus (BE).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-04 |
What the finished NCT01188980 record still lists
NCT01188980 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01188980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01188980 about?
NCT01188980 is a clinical study titled "Early Increase in Blood Supply in Patients With Barrett's Esophagus". The purpose of this study is to determine if early Barrett's specialized intestinal metaplasia can be detected by measuring early increased blood supply of the esophageal tissue, with 4 Dimensional Elastic Light-Scattering Fingerprinting, (4D-ELF) technology in real time.
What is the current status of trial NCT01188980?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2010-06. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT01188980?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia